IDEC-114: Phase I/II results; Phase II

In a Phase I/II dose-ranging trial of IDEC-114 in 35 patients with moderate to

Read the full 142 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE